Clinical evaluation of serum N-acetyl-beta-D-glucosaminidase as a liver function test.
Serum N-acetyl-beta-D-glucosaminidase has been shown to be a sensitive indicator of liver function. The enzyme activity in serum from patients with different forms of hepatic disease was found to be elevated. A comparison is also made with routine liver parameters. The frequencies of pathological serum levels of the routine measurements made are in relatively good agreement with earlier reports.
Severini
G
G
Laboratory Biochimica Clinica, Istituto Superiore di Sanità, Rome, Italy.
Aliberti
L M
LM
Koch
M
M
Capurso
L
L
Tarquini
M
M
D000118:Acetylglucosaminidase / Q000097:blood*; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002779:Cholestasis / Q000175:diagnosis / Q000201:enzymology; D003937:Diagnosis, Differential; D005069:Evaluation Studies as Topic; D006505:Hepatitis / Q000175:diagnosis / Q000201:enzymology; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000201:enzymology; D008107:Liver Diseases / Q000175:diagnosis* / Q000201:enzymology; D008111:Liver Function Tests / Q000379:methods*; D008297:Male; D012016:Reference Values; D005723:gamma-Glutamyltransferase / Q000097:blood
D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000118:Acetylglucosaminidase